Home
›
Outlook Therapeutics, Inc.
› SCHEDULE 13G/A Feb 5, 2026
Outlook Therapeutics, Inc. (OTLK): SCHEDULE 13G/A filed Feb 5, 2026
Form type
SCHEDULE 13G/A
Filing date
Feb 5, 2026
Accession number
0001178913-26-000311
Filer
Outlook Therapeutics, Inc.
(CIK 1649989)